DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 130 filers reported holding DIPLOMAT PHARMACY INC in Q3 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $81,000 | -31.9% | 20,338 | -16.0% | 0.00% | -50.0% |
| Q3 2019 | $119,000 | -75.2% | 24,203 | -69.2% | 0.00% | -77.8% |
| Q2 2019 | $479,000 | -40.4% | 78,658 | -43.2% | 0.01% | -65.4% |
| Q1 2019 | $804,000 | +422.1% | 138,372 | +1106.6% | 0.03% | +271.4% |
| Q4 2018 | $154,000 | -69.5% | 11,468 | -55.9% | 0.01% | -75.0% |
| Q3 2018 | $505,000 | +43.5% | 26,013 | +88.8% | 0.03% | +55.6% |
| Q2 2018 | $352,000 | +648.9% | 13,780 | +492.2% | 0.02% | +500.0% |
| Q1 2018 | $47,000 | -56.1% | 2,327 | -56.4% | 0.00% | -50.0% |
| Q4 2017 | $107,000 | -86.1% | 5,341 | -85.6% | 0.01% | -86.0% |
| Q3 2017 | $770,000 | +48.6% | 37,164 | +6.2% | 0.04% | +30.3% |
| Q2 2017 | $518,000 | -23.7% | 34,987 | +48.1% | 0.03% | -2.9% |
| Q3 2015 | $679,000 | +6.1% | 23,622 | +65.2% | 0.03% | +9.7% |
| Q2 2015 | $640,000 | – | 14,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |